TrialClinical cancer research : an official journal of the American Association for Cancer Research2013

Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer.

A J Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.